Breast Cancer Diagnostics Market Size Is Expected To Reach USD 8.4 Billion By 2026

San Francisco, 23 Nov 2020: The Report Breast Cancer Diagnostics Market Size, Share & Trends Analysis Report By Type (Imaging, Biopsy, Genomic Tests, Blood Tests), By Region, And Segment Forecasts, 2019 - 2026

The global breast cancer diagnostics market is expected to reach USD 8.4 billion by 2026, expanding at a 7.7.% CAGR during the forecast period, according to a new report by Grand View Research, Inc. Factors such as growing incidence of breast cancer and increasing healthcare spending and research activities are projected to drive the growth.

Breast cancer is the leading cause of cancer-related death among women and is the most common type of cancer overall. As per the World Cancer Research Fund (WCRF) International, around 2 million new breast cancer cases were recorded globally in 2018. According to Breastcancer.org, in U.S., around one in every women will be diagnosed with invasive breast cancer during her lifetime. It is projected that around 268,600 new cases of invasive breast cancer will be detected in U.S., in 2019.

Healthcare organizations and governments are striving to raise awareness regarding early diagnosis of the disease, through various independent and collaborative initiatives. Furthermore, research entities, along with private and public organizations, are heavily investing in research projects to develop advanced breast cancer diagnostics, which can diagnose the disease even before the symptoms appear.

Based on type, the imaging segment accounted for the largest share of the breast cancer diagnostics market in 2018 due to the increasing prevalence of the disease. Availability of various imaging methods such as breast MRI, ultrasonography, diagnostic mammography, and screening mammography is anticipated to bode well for the growth. These tests enable quick and accurate diagnosis. In addition, owing to the new technologically advanced techniques such as contrast-enhanced digital mammography, the segment is expected to maintain its dominance over the forecast period. The new techniques can detect the disease a little earlier by revealing growth of the blood vessels related to the tumor.

Access Research Report of Breast Cancer Diagnostics Market @ https://www.grandviewresearch.com/industry-analysis/breast-cancer-diagnostics-market

Further key findings from the report suggest:

  • The blood test is expected to be the fastest growing segment over the forecast period owing to the launch of new blood tests. For instance, The Heidelberg University Hospital in Germany introduced a test that can detect breast tumor quickly and noninvasively using biomarkers in the blood
  • North America was the largest revenue generating region in 2018 followed by Europe. High R&D activities, well-established diagnostic infrastructure, patient awareness, and presence of key players are some of the factor attributed to their continued dominance
  • Asia Pacific is expected to witness the fastest CAGR during the forecast period owing to the presence of large population base, target population, and high unmet clinical needs
  • Few major players operating in the breast cancer diagnostics market are Myriad Genetics, Inc.; Genomic Health; Hologic Inc.; NanoString Technologies, Inc.; Danaher; Koninklijke Philips N.V.; Becton, Dickinson and Company; Devicor Medical Products Inc.; and C.R. Bard, Inc.
  • The key players are adopting different strategies such as product development, collaborations, and geographic expansion to increase their market share.

Browse more reports of this category by Grand View Research at: https://www.grandviewresearch.com/industry/clinical-diagnostics

Grand View Research has segmented the global breast cancer diagnostics market based on type and region:

Breast Cancer Diagnostics Type Outlook (Revenue, USD Million, 2015 - 2026)

  • Imaging
  • Biopsy
  • Genomic Tests
  • Blood Tests
  • Others

Breast Cancer Diagnostics Regional Outlook (Revenue, USD Million, 2015 - 2026)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of Breast Cancer Diagnostics Market @ https://www.grandviewresearch.com/press-release/global-breast-cancer-diagnostics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information:www.grandviewresearch.com

 

Comments

Post a Comment

Popular posts from this blog

Asia Pacific PoC Diagnostics Market Growth Opportunities, Industry Analysis And Forecast: Grand View Research Inc.

Image
San Francisco, 18 March 2020 :  The Report   Asia Pacific PoC Diagnostics Market  Analysis And Segment Forecasts To 2020 The Asia Pacific point of care (PoC) diagnostics market is expected to reach USD 5,427.1 million by 2020, according to a new study by Grand View Research, Inc. Growing base of geriatric population and the ability to render immediate results and improve patient care coupled with rising market penetration of PACS (picture archiving and communication systems) and EMR (electronic medical records) are expected to drive demand over the next six years. Skilled staff shortages, especially pertaining to the field of diagnostics are also expected to accelerate the market penetration rates of PoC products, by expediting lab automation processes. Rising demand for home healthcare and other healthcare establishments catering to the elderly population and initiatives undertaken by governments to shorten hospital stays by establishing out-patient care models are also expect
Read more

Food Additives Market Size & Share Hit USD 55.53 Billion By 2022 : Grand View Research Inc.

Image
San Francisco, 17 October 2019:   The Report   Global Food Additives Market   Analysis By Product Flavors & Enhancers (Natural, Artificial), Sweeteners (High Intensity, HFCS), Enzymes, Emulsifiers (Mono, Di-Glycerides, Lecithin, Stearoyl Lactylates, Sorbitan Esters), Shelf-life Stabilizers, Fat Replacers (Protein, Starch)] And Segment Forecast To 2022 Global food additives market is expected to reach USD 55.53 billion by 2022, according to a new study by Grand View Research, Inc. Food & beverage industry growth in BRICS and Middle East on account of rising domestic consumption and increasing foreign direct investments is expected to augment market growth. Asia Pacific is expected to be one of the most promising markets on account of growing domestic consumption in China and India owing to population growth and new product launches by food & beverage manufacturers. Availability of raw materials such as sorbitol and lactic acid in China, Indonesia, and Malaysia in light o
Read more

Integration Platform as a Service Market Valuation Is Expected To Exceed USD 2.70 Billion By 2025: Grand View Research Inc.

Image
San Francisco, 18 March 2020 :  The Report   Integration Platform as a Service (IPaaS) Market  Analysis By Integration Type (API, Process, Application, Data), By Services, By Deployment (Cloud, On-Premise, Hybrid) By Region, And Segment Forecasts, 2018 – 2025 The global integration platform as a service (IPaaS) market is expected to reach USD 2.705.8 million by 2025, according to a new report by Grand View Research, Inc. Rising need of advanced systems to improve the process of deploying, developing, and managing enterprise applications globally has been a major factor driving market growth. In addition, recent developments in big data, cloud computing, and Internet of Things (IoT) within organizations’ processes also paved the way for greater development of IPaaS solutions. Integration Platform as a Service is an emerging technology where in the applications, process, data, and application programs are integrated. The integration enables enterprises to reduce the complexity
Read more